Patents by Inventor Shama Nasim

Shama Nasim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melampomagnolide B derivatives as antileukemic and cytotoxic agents
    Patent number: 8884027
    Abstract: Melampomagnolide B is disclosed as a new antileukemic sesquiterpene. A biotin-conjugated derivative of melampomagnolide B was prepared to elucidate its mechanism of action. Prodrugs of Melampomagnolide B are disclosed.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: November 11, 2014
    Assignees: University of Rochester, University of Kentucky Research Foundation
    Inventors: Peter A. Crooks, Craig T. Jordan, Shanshan Pei, Shama Nasim
  • Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
    Publication number: 20120122943
    Abstract: Melampomagnolide B is disclosed as a new antileukemic sesquiterpene. A biotin-conjugated derivative of melampomagnolide B was prepared to elucidate its mechanism of action. Prodrugs of Melampomagnolide B are disclosed.
    Type: Application
    Filed: October 21, 2011
    Publication date: May 17, 2012
    Applicant: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Peter A. Crooks, Craig T. Jordan, Shanshan Pei, Shama Nasim